| scholarly article | Q13442814 |
| P50 | author | Edward G. Lakatta | Q32985045 |
| Angus C. Nairn | Q37621746 | ||
| Jeffery D. Molkentin | Q54858774 | ||
| Margaret V Westfall | Q67654918 | ||
| P2093 | author name string | Su Wang | |
| James A Bibb | |||
| Anna A DePaoli-Roach | |||
| Jeffrey Robbins | |||
| Stephen B Liggett | |||
| Evangelia G Kranias | |||
| Wen Zhao | |||
| Timothy E Hewett | |||
| Ilona Bodi | |||
| John N Lorenz | |||
| Julian C Braz | |||
| Raisa Klevitsky | |||
| Thomas F Kimball | |||
| Arnold Schwartz | |||
| Bogachan Sahin | |||
| Kimberly Gregory | |||
| Anand Pathak | |||
| P2860 | cites work | Protein Kinase Cα Negatively Regulates Systolic and Diastolic Function in Pathological Hypertrophy | Q23913471 |
| Phosphorylation of protein phosphatase inhibitor-1 by Cdk5 | Q24091381 | ||
| Role of troponin I phosphorylation in protein kinase C-mediated enhanced contractile performance of rat myocytes | Q28180214 | ||
| Evidence for protein phosphatase inhibitor-1 playing an amplifier role in beta-adrenergic signaling in cardiac myocytes | Q28201819 | ||
| Identification of the major protein phosphatases in mammalian cardiac muscle which dephosphorylate phospholamban | Q28280839 | ||
| Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy | Q28505358 | ||
| PKC alpha regulates the hypertrophic growth of cardiomyocytes through extracellular signal-regulated kinase1/2 (ERK1/2) | Q28567395 | ||
| Ischemic Preconditioning Induces Selective Translocation of Protein Kinase C Isoforms and in the Heart of Conscious Rabbits Without Subcellular Redistribution of Total Protein Kinase C Activity | Q29041800 | ||
| beta-adrenergic receptor blockade in chronic heart failure | Q33831388 | ||
| Protein kinase C isozymes and the regulation of diverse cell responses | Q34012841 | ||
| Type 1 phosphatase, a negative regulator of cardiac function | Q34281889 | ||
| MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy, and heart failure | Q34416947 | ||
| Pharmacologic therapy for patients with chronic heart failure and reduced systolic function: review of trials and practical considerations | Q35120861 | ||
| Phospholamban: a crucial regulator of cardiac contractility | Q35167969 | ||
| Clinical use of inotropic therapy for heart failure: looking backward or forward? Part II: chronic inotropic therapy | Q35186772 | ||
| Compensatory mechanisms associated with the hyperdynamic function of phospholamban-deficient mouse hearts | Q36835427 | ||
| c-Jun N-terminal kinases (JNK) antagonize cardiac growth through cross-talk with calcineurin-NFAT signaling | Q39927730 | ||
| The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice | Q40388321 | ||
| Cardiac function and electrical remodeling of the calcineurin-overexpressed transgenic mouse | Q44025935 | ||
| Chronic suppression of heart-failure progression by a pseudophosphorylated mutant of phospholamban via in vivo cardiac rAAV gene delivery | Q45888008 | ||
| Robust Adenoviral and Adeno-Associated Viral Gene Transfer to the In Vivo Murine Heart | Q58198543 | ||
| Calcineurin promotes protein kinase C and c-Jun NH2-terminal kinase activation in the heart. Cross-talk between cardiac hypertrophic signaling pathways | Q64380804 | ||
| The phospholamban phosphatase associated with cardiac sarcoplasmic reticulum is a type 1 enzyme | Q67485704 | ||
| Targetting of protein phosphatase 1 to the sarcoplasmic reticulum of rabbit skeletal muscle by a protein that is very similar or identical to the G subunit that directs the enzyme to glycogen | Q68459342 | ||
| Alterations in protein kinase C isoenzyme expression and autophosphorylation during the progression of pressure overload-induced left ventricular hypertrophy | Q73085640 | ||
| Increased expression of protein kinase C isoforms in heart failure due to myocardial infarction | Q73384342 | ||
| Enhanced PKC beta II translocation and PKC beta II-RACK1 interactions in PKC epsilon-induced heart failure: a role for RACK1 | Q77174180 | ||
| Increased protein kinase C activity and expression of Ca2+-sensitive isoforms in the failing human heart | Q77905043 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | heart failure | Q181754 |
| Protein kinase C, alpha | Q14912658 | ||
| Protein phosphatase 1 catalytic subunit alpha | Q21981223 | ||
| Protein phosphatase 1, regulatory inhibitor subunit 1A | Q21987431 | ||
| P304 | page(s) | 248-254 | |
| P577 | publication date | 2004-02-15 | |
| P1433 | published in | Nature Medicine | Q1633234 |
| P1476 | title | PKC-alpha regulates cardiac contractility and propensity toward heart failure | |
| P478 | volume | 10 |
| Q48543585 | A Calcium- and Diacylglycerol-Stimulated Protein Kinase C (PKC), Caenorhabditis elegans PKC-2, Links Thermal Signals to Learned Behavior by Acting in Sensory Neurons and Intestinal Cells |
| Q60046045 | A secretory pathway kinase regulates sarcoplasmic reticulum Ca homeostasis and protects against heart failure |
| Q24337738 | A thrombospondin-dependent pathway for a protective ER stress response |
| Q36707489 | AAV9.I-1c delivered via direct coronary infusion in a porcine model of heart failure improves contractility and mitigates adverse remodeling |
| Q37874426 | AKAP phosphatase complexes in the heart |
| Q36122838 | AZT-induced mitochondrial toxicity: an epigenetic paradigm for dysregulation of gene expression through mitochondrial oxidative stress |
| Q61844885 | Abruptio placentae risk and genetic variations in mitochondrial biogenesis and oxidative phosphorylation: replication of a candidate gene association study. |
| Q35203675 | Absence of PKC-alpha attenuates lithium-induced nephrogenic diabetes insipidus |
| Q46884598 | Activation of protein kinase C in sensory neurons accelerates Ca2+ uptake into the endoplasmic reticulum. |
| Q35228540 | Activation of protein kinase C-α and Src kinase increases urea transporter A1 α-2, 6 sialylation |
| Q28581250 | Adenovirus-delivered short hairpin RNA targeting PKCalpha improves contractile function in reconstituted heart tissue |
| Q44970310 | Adenylyl cyclase type VI corrects cardiac sarcoplasmic reticulum calcium uptake defects in cardiomyopathy |
| Q89974210 | Advanced glycation end products facilitate the proliferation and reduce early apoptosis of cardiac microvascular endothelial cells via PKCβ signaling pathway: Insight from diabetic cardiomyopathy |
| Q37766138 | Advances in gene-based therapy for heart failure |
| Q36920937 | Agonist activated PKCβII translocation and modulation of cardiac myocyte contractile function. |
| Q34017983 | Aliskiren ameliorates pressure overload-induced heart hypertrophy and fibrosis in mice |
| Q37692816 | Alpha-1-adrenergic receptors in heart failure: the adaptive arm of the cardiac response to chronic catecholamine stimulation |
| Q53073431 | Alpha-2 adrenoceptors and imidazoline receptors in cardiomyocytes mediate counterbalancing effect of agmatine on NO synthesis and intracellular calcium handling. |
| Q27014882 | Alteration of energy substrates and ROS production in diabetic cardiomyopathy |
| Q37239340 | Alterations in ryanodine receptors and related proteins in heart failure |
| Q28579214 | Altered PKC expression and phosphorylation in response to the nature, direction, and magnitude of mechanical stretch |
| Q50043956 | Altered Repolarization Reserve in Failing Rabbit Ventricular Myocytes: Calcium and β-Adrenergic Effects on Delayed- and Inward-Rectifier Potassium Currents. |
| Q30444270 | Altered contractility and [Ca2+]i homeostasis in phospholemman-deficient murine myocytes: role of Na+/Ca2+ exchange |
| Q33683757 | Altered intracellular Ca2+ handling in heart failure |
| Q42922738 | An allosteric modulator of the adenosine A1 receptor improves cardiac function following ischaemia in murine isolated hearts. |
| Q50035208 | Anarchy in the UPR: A Ca2+-insensitive PKC inhibits SERCA activity to promote ER stress |
| Q47552122 | Angiotensin II Overstimulation Leads to an Increased Susceptibility to Dilated Cardiomyopathy and Higher Mortality in Female Mice |
| Q35545375 | Angiotensin II acutely decreases myocardial stiffness: a novel AT1, PKC and Na+/H+ exchanger-mediated effect. |
| Q46628023 | Angiotensin II-induced negative inotropy in rat ventricular myocytes: role of reactive oxygen species and p38 MAPK. |
| Q37328072 | Antisense makes sense in engineered regenerative medicine |
| Q28237326 | Apelin increases cardiac contractility via protein kinase Cε- and extracellular signal-regulated kinase-dependent mechanisms |
| Q36788875 | Arrhythmogenic ion-channel remodeling in the heart: heart failure, myocardial infarction, and atrial fibrillation. |
| Q58614496 | Assessment of PKA and PKC inhibitors on force and kinetics of non-failing and failing human myocardium |
| Q39124878 | Breviscapine ameliorates hypertrophy of cardiomyocytes induced by high glucose in diabetic rats via the PKC signaling pathway |
| Q35902097 | CCK causes PKD1 activation in pancreatic acini by signaling through PKC-delta and PKC-independent pathways |
| Q39493909 | Ca2+ cycling and new therapeutic approaches for heart failure |
| Q37129336 | Ca2+-operated transcriptional networks: molecular mechanisms and in vivo models. |
| Q42497679 | Calcitriol modulation of cardiac contractile performance via protein kinase C. |
| Q92701787 | Calcium as a Key Player in Arrhythmogenic Cardiomyopathy: Adhesion Disorder or Intracellular Alteration? |
| Q48022323 | Calcium handler mishandles heart |
| Q33787533 | Calcium sensitivity, force frequency relationship and cardiac troponin I: critical role of PKA and PKC phosphorylation sites |
| Q36660414 | Calcium signaling phenomena in heart diseases: a perspective |
| Q37063637 | Calcium sparklets in arterial smooth muscle |
| Q42505294 | Calcium sparklets regulate local and global calcium in murine arterial smooth muscle |
| Q35842857 | Cardiac GPCRs: GPCR signaling in healthy and failing hearts |
| Q34409721 | Cardiac Gene Therapy |
| Q48118068 | Cardiac RKIP induces a beneficial β-adrenoceptor-dependent positive inotropy. |
| Q36638771 | Cardiac actions of protein kinase C isoforms |
| Q37432103 | Cardiac alpha1-adrenergic receptors: novel aspects of expression, signaling mechanisms, physiologic function, and clinical importance |
| Q92319811 | Cardiac contractile dysfunction and protein kinase C-mediated myofilament phosphorylation in disease and aging |
| Q36824112 | Cardiac lipotoxicity: molecular pathways and therapeutic implications |
| Q48004442 | Cardiac overexpression of Epac1 in transgenic mice rescues lipopolysaccharide-induced cardiac dysfunction and inhibits Jak-STAT pathway |
| Q36267790 | Cardiac stem cells and mechanisms of myocardial regeneration |
| Q48384457 | Cardiac-specific overexpression of diacylglycerol kinase zeta attenuates left ventricular remodeling and improves survival after myocardial infarction |
| Q37953767 | Cardiomyocyte calcineurin signaling in subcellular domains: from the sarcolemma to the nucleus and beyond |
| Q34718192 | Cardiomyocyte lipids impair β-adrenergic receptor function via PKC activation |
| Q34396881 | Cardiomyocyte-specific loss of diacylglycerol acyltransferase 1 (DGAT1) reproduces the abnormalities in lipids found in severe heart failure |
| Q36065247 | Caveolin-3 Overexpression Attenuates Cardiac Hypertrophy via Inhibition of T-type Ca2+ Current Modulated by Protein Kinase Cα in Cardiomyocytes |
| Q40292806 | Characterization of a novel protein kinase D: Caenorhabditis elegans DKF-1 is activated by translocation-phosphorylation and regulates movement and growth in vivo |
| Q36064578 | Chronic Contractile Dysfunction without Hypertrophy Does Not Provoke a Compensatory Transcriptional Response in Mouse Hearts |
| Q45188996 | Chronic exercise improves myocardial inotropic reserve capacity through alpha1-adrenergic and protein kinase C-dependent effects in Senescent rats. |
| Q27320196 | Circulating Pneumolysin Is a Potent Inducer of Cardiac Injury during Pneumococcal Infection |
| Q36367548 | Combined cardiomyocyte PKCδ and PKCε gene deletion uncovers their central role in restraining developmental and reactive heart growth |
| Q34149773 | Common variants in 22 loci are associated with QRS duration and cardiac ventricular conduction |
| Q36653535 | Constitutive phosphorylation of inhibitor-1 at Ser67 and Thr75 depresses calcium cycling in cardiomyocytes and leads to remodeling upon aging |
| Q42182103 | Constitutively active phosphatase inhibitor-1 improves cardiac contractility in young mice but is deleterious after catecholaminergic stress and with aging |
| Q54125003 | Contractile responses to endothelin-1 are regulated by PKC phosphorylation of cardiac myosin binding protein-C in rat ventricular myocytes. |
| Q39613493 | Convergence of protein kinase C and JAK-STAT signaling on transcription factor GATA-4. |
| Q26776182 | Counteracting Protein Kinase Activity in the Heart: The Multiple Roles of Protein Phosphatases |
| Q43896155 | Decoy peptides targeted to protein phosphatase 1 inhibit dephosphorylation of phospholamban in cardiomyocytes |
| Q34409221 | Defects in T-tubular electrical activity underlie local alterations of calcium release in heart failure |
| Q37299072 | Designing heart performance by gene transfer. |
| Q46087965 | Detrimental effect of combined exercise training and eNOS overexpression on cardiac function after myocardial infarction |
| Q57186141 | Diabetic cardiomyopathy |
| Q85638700 | Diabetic cardiomyopathy: ongoing controversies in 2012 |
| Q37882500 | Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatment. |
| Q46503338 | Diastolic dysfunction in alveolar hypoxia: a role for interleukin-18-mediated increase in protein phosphatase 2A. |
| Q33986250 | Differential activation of stress-response signaling in load-induced cardiac hypertrophy and failure |
| Q39861257 | Direct interaction between myocyte enhancer factor 2 (MEF2) and protein phosphatase 1alpha represses MEF2-dependent gene expression. |
| Q30275866 | Disease Phenotypes in a Mouse Model of RNA Toxicity Are Independent of Protein Kinase Cα and Protein Kinase Cβ |
| Q39162238 | Diversity and plasticity in signaling pathways that regulate smooth muscle responsiveness: Paradigms and paradoxes for the myosin phosphatase, the master regulator of smooth muscle contraction |
| Q37516514 | Doxazosin Stimulates Galectin-3 Expression and Collagen Synthesis in HL-1 Cardiomyocytes Independent of Protein Kinase C Pathway |
| Q35581334 | Doxercalciferol, a pro-hormone of vitamin D, prevents the development of cardiac hypertrophy in rats |
| Q41809741 | Dual regulation of glycogen synthase kinase 3 (GSK3)α/β by protein kinase C (PKC)α and Akt promotes thrombin-mediated integrin αIIbβ3 activation and granule secretion in platelets. |
| Q26799286 | Dynamics and Membrane Interactions of Protein Kinase C |
| Q37005395 | Early hemodynamic and biochemical changes in overloaded swine ventricle |
| Q36681254 | Ecto-5'-nucleotidase deficiency exacerbates pressure-overload-induced left ventricular hypertrophy and dysfunction. |
| Q41552899 | Effect of PKC inhibitor on experimental autoimmune myocarditis in Lewis rats |
| Q40012804 | Effect of troponin I Ser23/24 phosphorylation on Ca2+-sensitivity in human myocardium depends on the phosphorylation background |
| Q37190351 | Effects of thapsigargin and phenylephrine on calcineurin and protein kinase C signaling functions in cardiac myocytes |
| Q33655566 | Elevated Ca2+ sparklet activity during acute hyperglycemia and diabetes in cerebral arterial smooth muscle cells |
| Q26849244 | Endogenous inhibitor proteins that connect Ser/Thr kinases and phosphatases in cell signaling |
| Q43725907 | Enhanced calcium cycling and contractile function in transgenic hearts expressing constitutively active G alpha o* protein |
| Q33685872 | Epac1-dependent phospholamban phosphorylation mediates the cardiac response to stresses |
| Q40117988 | Erythropoietin induces positive inotropic and lusitropic effects in murine and human myocardium |
| Q70206948 | Essential role of GEXP15, a specific Protein Phosphatase type 1 partner, in Plasmodium berghei in asexual erythrocytic proliferation and transmission. |
| Q33787977 | Excision of titin's cardiac PEVK spring element abolishes PKCalpha-induced increases in myocardial stiffness |
| Q54643843 | Exercise preconditioning initiates late cardioprotection against isoproterenol-induced myocardial injury in rats independent of protein kinase C |
| Q40893022 | Expressing an inhibitor of PLCβ1b sustains contractile function following pressure overload |
| Q26739009 | Fatty old hearts: role of cardiac lipotoxicity in age-related cardiomyopathy |
| Q36754545 | Fish oil selectively improves heart function in a mouse model of lipid-induced cardiomyopathy |
| Q96640804 | Four Loci Are Associated with Cardiorespiratory Fitness and Endurance Performance in Young Chinese Females |
| Q57455677 | Frequency-dependent myofilament Ca2+ desensitization in failing rat myocardium |
| Q50598076 | Functional communication between PKC-targeted cardiac troponin I phosphorylation sites. |
| Q41789528 | Functional divergence of platelet protein kinase C (PKC) isoforms in thrombus formation on collagen. |
| Q33810086 | G alpha(q)-mediated activation of GRK2 by mechanical stretch in cardiac myocytes: the role of protein kinase C. |
| Q37898924 | G protein-dependent and G protein-independent signaling pathways and their impact on cardiac function |
| Q37546346 | G proteins Gαi1/3 are critical targets for Bordetella pertussis toxin-induced vasoactive amine sensitization |
| Q91606337 | Gene Therapy for Heart Failure: New Perspectives |
| Q28580441 | Gene expression profiling identifies regulatory pathways involved in the late stage of rat fetal lung development |
| Q34561377 | Gene expression, function and ischemia tolerance in male and female rat hearts after sub-toxic levels of angiotensin II. |
| Q38132253 | Gene therapy for heart disease: molecular targets, vectors and modes of delivery to myocardium |
| Q36786243 | Gene therapy in the treatment of heart failure |
| Q59192183 | Genetic Reduction in Left Ventricular Protein Kinase C-α and Adverse Ventricular Remodeling in Human Subjects |
| Q28654771 | Genetic association study of QT interval highlights role for calcium signaling pathways in myocardial repolarization |
| Q38894871 | Genetic variation associated with preterm birth in African-American women |
| Q64927023 | Genome-Wide Signatures of Selection Reveal Genes Associated With Performance in American Quarter Horse Subpopulations. |
| Q89964430 | Heart Plasticity in Response to Pressure- and Volume-Overload: A Review of Findings in Compensated and Decompensated Phenotypes |
| Q34386778 | Highly Specific Modulators of Protein Kinase C Localization: Applications to Heart Failure |
| Q38974621 | How cardiomyocytes sense pathophysiological stresses for cardiac remodeling. |
| Q33260648 | Identification of a novel phosphorylation site in protein phosphatase inhibitor-1 as a negative regulator of cardiac function. |
| Q34190265 | Identification of plasma membrane macro- and microdomains from wavelet analysis of FRET microscopy |
| Q36114228 | Immunosuppression decreases inflammation and increases AAV6-hSERCA2a-mediated SERCA2a expression |
| Q43114553 | Impaired IKs channel activation by Ca(2+)-dependent PKC shows correlation with emotion/arousal-triggered events in LQT1. |
| Q36968418 | Impaired cardiac contractility in mice lacking both the AE3 Cl-/HCO3- exchanger and the NKCC1 Na+-K+-2Cl- cotransporter: effects on Ca2+ handling and protein phosphatases |
| Q37101607 | Inducible and myocyte-specific inhibition of PKCalpha enhances cardiac contractility and protects against infarction-induced heart failure |
| Q37364808 | Inducible expression of active protein phosphatase-1 inhibitor-1 enhances basal cardiac function and protects against ischemia/reperfusion injury. |
| Q36464709 | Influence of protein kinase C (PKC) on the prognosis of diabetic nephropathy patients |
| Q35891484 | Inhibition of NAPDH Oxidase 2 (NOX2) Prevents Oxidative Stress and Mitochondrial Abnormalities Caused by Saturated Fat in Cardiomyocytes |
| Q35612752 | Inhibition of PKCα/β with ruboxistaurin antagonizes heart failure in pigs after myocardial infarction injury |
| Q51732685 | Inhibition of protein kinase C in diabetic nephropathy--where do we stand? |
| Q36995149 | Inhibitor-2 prevents protein phosphatase 1-induced cardiac hypertrophy and mortality |
| Q37415877 | Inositol 1, 4, 5-trisphosphate receptors and human left ventricular myocytes |
| Q36502630 | Integration of calcium with the signaling network in cardiac myocytes. |
| Q58556671 | Interplay Between Sub-Cellular Alterations of Calcium Release and T-Tubular Defects in Cardiac Diseases |
| Q35636210 | Interventricular differences in myofilament function in experimental congestive heart failure |
| Q37481307 | Involvement of PKC alpha and G-protein-coupled receptor kinase 2 in agonist-selective desensitization of mu-opioid receptors in mature brain neurons. |
| Q47291894 | Isoform α of PKC may contribute to the maintenance of pregnancy myometrial quiescence in humans |
| Q37021871 | K(ATP) channel gain-of-function leads to increased myocardial L-type Ca(2+) current and contractility in Cantu syndrome. |
| Q36200287 | Lack of protein kinase C-α leads to impaired urine concentrating ability and decreased aquaporin-2 in angiotensin II-induced hypertension |
| Q81731582 | Late-stage alterations in myofibrillar contractile function in a transgenic mouse model of dilated cardiomyopathy (Tgalphaq*44) |
| Q38329524 | Leptin repletion restores depressed {beta}-adrenergic contractility in ob/ob mice independently of cardiac hypertrophy |
| Q37684850 | Lipid Use and Misuse by the Heart. |
| Q44175136 | Long QT2 mutation on the Kv11.1 ion channel inhibits current activity by ablating a protein kinase Cα consensus site. |
| Q46962473 | Long-term beta-adrenergic stimulation leads to downregulation of protein phosphatase inhibitor-1 in the heart |
| Q36837898 | Low molecular weight fibroblast growth factor-2 signals via protein kinase C and myofibrillar proteins to protect against postischemic cardiac dysfunction |
| Q37061259 | MLP and CARP are linked to chronic PKCα signalling in dilated cardiomyopathy |
| Q33576908 | Mammalian target of rapamycin is a critical regulator of cardiac hypertrophy in spontaneously hypertensive rats. |
| Q37715817 | Mammalian target of rapamycin signaling in cardiac physiology and disease. |
| Q37025393 | Mechanisms and pharmacogenetic signals underlying thiazide diuretics blood pressure response |
| Q27012758 | Mechanisms of altered Ca²⁺ handling in heart failure |
| Q63131766 | Mechanisms of physiological and pathological cardiac hypertrophy |
| Q36295739 | Mechanisms underlying heterogeneous Ca2+ sparklet activity in arterial smooth muscle |
| Q33767865 | MicroRNAs coordinate an alternative splicing network during mouse postnatal heart development |
| Q45930105 | Mitochondrial Integrity and Function in the Progression of Early Pressure Overload-Induced Left Ventricular Remodeling. |
| Q24337593 | Modulation of cardiac contractility by the phospholamban/SERCA2a regulatome |
| Q35936390 | Molecular genetics and genomics of heart failure |
| Q36526222 | Molecular mechanisms underlying cardiac protein phosphatase 2A regulation in heart |
| Q41855920 | Molecular pathways underlying cardiac remodeling during pathophysiological stimulation |
| Q35328760 | Myocardial stiffness in patients with heart failure and a preserved ejection fraction: contributions of collagen and titin |
| Q41741744 | Myofibril growth during cardiac hypertrophy is regulated through dual phosphorylation and acetylation of the actin capping protein CapZ |
| Q37367307 | Myofilament dysfunction in cardiac disease from mice to men. |
| Q44296034 | N-n-butyl haloperidol iodide preserves cardiomyocyte calcium homeostasis during hypoxia/ischemia |
| Q36496949 | Negative regulation of cyclin-dependent kinase 5 targets by protein kinase C |
| Q56335220 | Network-based predictions of in vivo cardiac hypertrophy |
| Q99632204 | Neurohormonal Regulation of IKs in Heart Failure: Implications for Ventricular Arrhythmogenesis and Sudden Cardiac Death |
| Q48506350 | New Insights Into the Role of mTOR Signaling in the Cardiovascular System. |
| Q41856322 | Novel strategies for the treatment of heart failure |
| Q35825873 | Novel therapeutic approaches for heart failure by normalizing calcium cycling |
| Q34297056 | Nuclear localization of a1A-adrenergic receptors is required for signaling in cardiac myocytes: an “inside-out” a1-AR signaling pathway |
| Q28581441 | Nuclear localization of protein kinase C-alpha induces thyroid hormone receptor-alpha1 expression in the cardiomyocyte |
| Q90025375 | Obstruction of ventricular Ca2+ -dependent arrhythmogenicity by inositol 1,4,5-trisphosphate-triggered sarcoplasmic reticulum Ca2+ release |
| Q46753015 | Overexpression of diacylglycerol kinase zeta inhibits endothelin-1-induced decreases in Ca2+ transients and cell shortening in mouse ventricular myocytes |
| Q33624234 | Oxidative Stress-Induced Afterdepolarizations and Protein Kinase C Signaling |
| Q33872491 | PDE5 inhibitor efficacy is estrogen dependent in female heart disease |
| Q39373745 | PICOT increases cardiac contractility by inhibiting PKCζ activity |
| Q34534789 | PKC activation by resveratrol derivatives with unsaturated aliphatic chain |
| Q40341180 | PKC alpha-dependent regulation of the IGF1 receptor in adult and embryonic rat cardiomyocytes |
| Q64080450 | PKC and PKN in heart disease |
| Q30492100 | PKC inhibition ameliorates the cardiac phenotype in a mouse model of myotonic dystrophy type 1. |
| Q41910388 | PKC-ε mediates multiple endothelin-1 actions on systolic Ca2+ and contractility in ventricular myocytes |
| Q28505136 | PKCalpha regulates platelet granule secretion and thrombus formation in mice |
| Q33405817 | PKCα negatively regulates in vitro proplatelet formation and in vivo platelet production in mice. |
| Q35014341 | PKCα-specific phosphorylation of the troponin complex in human myocardium: a functional and proteomics analysis |
| Q30524184 | PKCβII modulation of myocyte contractile performance |
| Q91564386 | PKCβII specifically regulates KCNQ1/KCNE1 channel membrane localization |
| Q38709683 | PM2.5 exposure in utero contributes to neonatal cardiac dysfunction in mice |
| Q38922797 | Pathophysiology of the Desmo-Adhesome |
| Q34018767 | Peroxynitrite Increases Protein Phosphatase Activity and Promotes the Interaction of Phospholamban with Protein Phosphatase 2a in the Myocardium. |
| Q54110304 | Pharmacological inhibition of the mitochondrial NADPH oxidase 4/PKCα/Gal-3 pathway reduces left ventricular fibrosis following myocardial infarction. |
| Q37254944 | Pharmacological- and gene therapy-based inhibition of protein kinase Calpha/beta enhances cardiac contractility and attenuates heart failure |
| Q37138934 | Phosphoinositide 3-kinase Akt signaling pathway interacts with protein kinase Cbeta2 in the regulation of physiologic developmental hypertrophy and heart function |
| Q98775671 | Phosphoproteomic analysis identifies phospho-Threonine-17 site of phospholamban important in low molecular weight isoform of fibroblast growth factor 2-induced protection against post-ischemic cardiac dysfunction |
| Q35158657 | Phosphorylation of protein phosphatase inhibitor-1 by protein kinase C. |
| Q35167070 | Preventing progression of cardiac hypertrophy and development of heart failure by paricalcitol therapy in rats |
| Q46429282 | Prostanoid F receptors elicit an inotropic effect in rat left ventricle by enhancing myosin light chain phosphorylation |
| Q57396450 | Protein Kinase C Inhibition With Ruboxistaurin Increases Contractility and Reduces Heart Size in a Swine Model of Heart Failure With Reduced Ejection Fraction |
| Q33678033 | Protein Kinases as Drug Development Targets for Heart Disease Therapy |
| Q28253877 | Protein kinase C alpha and epsilon phosphorylation of troponin and myosin binding protein C reduce Ca2+ sensitivity in human myocardium |
| Q42795655 | Protein kinase C alpha enhances sodium–calcium exchange during store-operated calcium entry in mouse platelets |
| Q46628001 | Protein kinase C and preconditioning: role of the sarcoplasmic reticulum |
| Q46317401 | Protein kinase C contributes to the maintenance of contractile force in human ventricular cardiomyocytes |
| Q36599563 | Protein kinase C depresses cardiac myocyte power output and attenuates myofilament responses induced by protein kinase A |
| Q37176180 | Protein kinase C in heart failure: a therapeutic target? |
| Q39827153 | Protein kinase C isoforms differentially phosphorylate Ca(v)1.2 alpha(1c). |
| Q81578747 | Protein kinase C isozymes in hypertension and hypertrophy: insight from SHHF rat hearts |
| Q28075729 | Protein kinase C mechanisms that contribute to cardiac remodelling |
| Q37141320 | Protein kinase C, an elusive therapeutic target? |
| Q33654370 | Protein kinase C-alpha suppresses autophagy and induces neural tube defects via miR-129-2 in diabetic pregnancy |
| Q44991365 | Protein kinase C-alpha-induced hypertrophy of neonatal rat ventricular myocytes |
| Q35994513 | Protein kinase C-α mediates hypertonicity-stimulated increase in urea transporter phosphorylation in the inner medullary collecting duct |
| Q37882868 | Protein kinase C: the "masters" of calcium and lipid |
| Q37647208 | Protein kinase Calpha: disease regulator and therapeutic target. |
| Q44942586 | Protein kinase Cepsilon and the antiadrenergic action of adenosine in rat ventricular myocytes |
| Q37359189 | Protein kinase C{alpha}, but not PKC{beta} or PKC{gamma}, regulates contractility and heart failure susceptibility: implications for ruboxistaurin as a novel therapeutic approach |
| Q34170640 | Protein kinase Cα (PKCα) regulates bone architecture and osteoblast activity. |
| Q35480691 | Protein kinase Cα as a heart failure therapeutic target |
| Q47421364 | Protein kinase Cα deletion causes hypotension and decreased vascular contractility. |
| Q38849785 | Protein kinase Cα inhibits myocardin-induced cardiomyocyte hypertrophy through the promotion of myocardin phosphorylation |
| Q34979083 | Protein kinase Cα signaling regulates inhibitor of DNA binding 1 in the intestinal epithelium |
| Q34545363 | Protein kinase Cθ is required for cardiomyocyte survival and cardiac remodeling. |
| Q24518494 | Protein kinase cascades in the regulation of cardiac hypertrophy |
| Q24561772 | Protein kinases C and D mediate agonist-dependent cardiac hypertrophy through nuclear export of histone deacetylase 5 |
| Q37428610 | Protein phosphatase 2A is regulated by protein kinase Cα (PKCα)-dependent phosphorylation of its targeting subunit B56α at Ser41. |
| Q37368686 | Reactivation of fetal splicing programs in diabetic hearts is mediated by protein kinase C signaling. |
| Q38196174 | Reactive oxygen species and excitation-contraction coupling in the context of cardiac pathology |
| Q45873132 | Recent findings into the potential of gene therapy to reverse heart failure |
| Q34168662 | Receptor-Independent Cardiac Protein Kinase Cα Activation by Calpain-Mediated Truncation of Regulatory Domains |
| Q35128304 | Receptor-independent protein kinase C alpha (PKCalpha) signaling by calpain-generated free catalytic domains induces HDAC5 nuclear export and regulates cardiac transcription |
| Q38035382 | Redox regulation of sodium and calcium handling |
| Q81565804 | Reduced inhibitor 1 and 2 activity is associated with increased protein phosphatase type 1 activity in left ventricular myocardium of one-kidney, one-clip hypertensive rats |
| Q37971764 | Regulation of cardiac excitability by protein kinase C isozymes |
| Q38944079 | Regulation of sarcoplasmic reticulum Ca2+ release by serine-threonine phosphatases in the heart. |
| Q36562746 | Regulation of the sarcoplasmic reticulum Ca2+-ATPase expression in the hypertrophic and failing heart |
| Q48315224 | Regulatory Variants Modulate Protein Kinase C α (PRKCA) Gene Expression in Human Heart |
| Q37088473 | Remodeling of calcium handling in human heart failure |
| Q37964927 | Reverse remodeling in heart failure--mechanisms and therapeutic opportunities |
| Q37766125 | Revisited and revised: is RhoA always a villain in cardiac pathophysiology? |
| Q35185579 | RhoA/ROCK signaling and pleiotropic α1A-adrenergic receptor regulation of cardiac contractility. |
| Q37145537 | Role of PP1 in the regulation of Ca cycling in cardiac physiology and pathophysiology |
| Q88968512 | Role of cytokines and inflammation in heart function during health and disease |
| Q46443820 | Role of protein kinase C in metabolic regulation of the cardiac Na+ channel. |
| Q46353008 | Role of protein kinase Calpha in regulation of [Ca2+](I) and force in human myometrium |
| Q38820202 | Role of protein phosphatase inhibitor-1 in cardiac beta adrenergic pathway |
| Q37276968 | Role of protein phosphatase-1 inhibitor-1 in cardiac physiology and pathophysiology |
| Q38109648 | SERCA2a: a prime target for modulation of cardiac contractility during heart failure |
| Q41768288 | Sarcolipin and phospholamban mRNA and protein expression in cardiac and skeletal muscle of different species. |
| Q26825154 | Signaling effectors underlying pathologic growth and remodeling of the heart |
| Q34300912 | Sildenafil stops progressive chamber, cellular, and molecular remodeling and improves calcium handling and function in hearts with pre-existing advanced hypertrophy caused by pressure overload |
| Q33720346 | Simultaneous loss of phospholipase Cδ1 and phospholipase Cδ3 causes cardiomyocyte apoptosis and cardiomyopathy |
| Q42778625 | Small heat shock protein 20 interacts with protein phosphatase-1 and enhances sarcoplasmic reticulum calcium cycling |
| Q36887547 | Small-molecule therapies for cardiac hypertrophy: moving beneath the cell surface |
| Q91525524 | Statin-specific inhibition of Rab-GTPase regulates cPKC-mediated IKs internalization |
| Q37193142 | Structural insights into phospholipase C-β function. |
| Q30525701 | Structure-activity studies of RFamide-related peptide-1 identify a functional receptor antagonist and novel cardiac myocyte signaling pathway involved in contractile performance. |
| Q39107046 | Sub-cellular localization specific SUMOylation in the heart |
| Q59360573 | Successful overexpression of wild-type inhibitor-2 of PP1 in cardiovascular cells |
| Q45858131 | Synergistic role of protein phosphatase inhibitor 1 and sarco/endoplasmic reticulum Ca2+ -ATPase in the acquisition of the contractile phenotype of arterial smooth muscle cells |
| Q35697884 | Systems Pharmacology Dissecting Holistic Medicine for Treatment of Complex Diseases: An Example Using Cardiocerebrovascular Diseases Treated by TCM |
| Q37089726 | Tackling heart failure in the twenty-first century |
| Q36642702 | Targeting angiogenesis versus myogenesis with cardiac cell therapy |
| Q46549512 | Targeting of PED/PEA-15 molecular interaction with phospholipase D1 enhances insulin sensitivity in skeletal muscle cells. |
| Q39232367 | Targetting PED/PEA-15 for diabetes treatment. |
| Q35918472 | The Effect of PKCα on the Light Response of Rod Bipolar Cells in the Mouse Retina |
| Q34103732 | The IP3 receptor regulates cardiac hypertrophy in response to select stimuli |
| Q28246833 | The MLCK-mediated alpha1-adrenergic inotropic effect in atrial myocardium is negatively modulated by PKCepsilon signaling |
| Q42145491 | The atypical 'b' splice variant of phospholipase Cβ1 promotes cardiac contractile dysfunction. |
| Q34592311 | The calcium ATPase SERCA2 regulates desmoplakin dynamics and intercellular adhesive strength through modulation of PKCα signaling |
| Q58110354 | The dominant protein phosphatase PP1c isoform in smooth muscle cells, PP1cβ, is essential for smooth muscle contraction |
| Q34700997 | The large isoforms of A-kinase anchoring protein 18 mediate the phosphorylation of inhibitor-1 by protein kinase A and the inhibition of protein phosphatase 1 activity. |
| Q38622658 | The role of mid-chain hydroxyeicosatetraenoic acids in the pathogenesis of hypertension and cardiac hypertrophy |
| Q39310482 | The role of protein kinase C-mediated phosphorylation of sarcomeric proteins in the heart-detrimental or beneficial? |
| Q37082359 | Toward biologically targeted therapy of calcium cycling defects in heart failure |
| Q47200854 | Transient activation of PKC results in long-lasting detrimental effects on systolic [Ca2+]i in cardiomyocytes by altering actin cytoskeletal dynamics and T-tubule integrity |
| Q40199219 | Treatment of heart failure by calcium cycling gene therapy |
| Q79325476 | Troponin phosphorylation and regulatory function in human heart muscle: dephosphorylation of Ser23/24 on troponin I could account for the contractile defect in end-stage heart failure |
| Q42915525 | VEGF-PLCgamma1 pathway controls cardiac contractility in the embryonic heart |
| Q37101602 | With great power comes great responsibility: using mouse genetics to study cardiac hypertrophy and failure |
| Q42690112 | alpha1G-dependent T-type Ca2+ current antagonizes cardiac hypertrophy through a NOS3-dependent mechanism in mice |
| Q40182849 | mTORC2 regulates cardiac response to stress by inhibiting MST1. |
| Q34976170 | p38α regulates SERCA2a function. |
| Q50141007 | α-ketoglutarate stimulates pendrin-dependent Cl- absorption in the mouse CCD through protein kinase C. |
| Q35103455 | βIIPKC and εPKC isozymes as potential pharmacological targets in cardiac hypertrophy and heart failure |
Search more.